SynthesisInternational journal of dermatology2021
Skin manifestations in COVID-19 patients, state of the art. A systematic review.
Synthesis in International journal of dermatology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 30 citations in OpenAlex.
- Diagnosis and management of COVID toes in outpatients: a case report.Journal of medical case reports · 2024Article
- Morphological and Prognostic Values of Skin Lesions in Patients with COVID-19.Dermatology research and practice · 2024Article
- COVID-19: THE NEED FOR INCREASED RECOGNITION OF CUTANEOUS MANIFESTATIONS - LETTER TO THE EDITOR.African journal of infectious diseases · 2023Article
- Increased Frequency of Hand Hygiene and Other Infection Prevention Practices Correlates with Reduced Surgical Wound Infection Rates in Spinal Surgery during the COVID-19 Pandemic.Journal of clinical medicine · 2022Article
- Cutaneous Manifestations in Patients With COVID-19 Treated at a University Hospital in Southern Brazil.Cureus · 2022Article
- Paucity of cutaneous manifestations of COVID-19 among inpatients at a referral hospital in India.JAAD international · 2022Article
- Herpes zoster in the era of COVID 19: A prospective observational study to probe the association of herpes zoster with COVID 19 infection and vaccination.Dermatologic therapy · 2022Observational
- The Impact of COVID-19 Pandemic on Dermatological Conditions: A Novel, Comprehensive Review.Dermatopathology (Basel, Switzerland) · 2022Review
- One Year of COVID-19: Lessons Learned in a Hand Trauma Center.Journal of clinical medicine · 2022Article
- Toxic Epidermal Necrolysis associated with COVID-19 infection: A case report.Clinical case reports · 2022Article
- Cutaneous manifestation of COVID-19: What have we learned an year into the pandemic?Actas dermo-sifiliograficas · 2022Review
- [Cutaneous Manifestation of COVID-19: What Have we Learned an Year Into the Pandemic?]Actas dermo-sifiliograficas · 2022Review
- Is it time to resume elective knee arthroplasty surgery? A multidisciplinary experience in a Sardinian center during the SARS-CoV-2 pandemic.Orthopedic reviews · 2022Review
- Cutaneous Eruptions in the Course of COVID-19 Among Geriatric Patients in a Nursing Home in Poland.Clinical, cosmetic and investigational dermatology · 2022Article
- Review
- COVID-19 and the clinical course of rheumatic manifestations.Clinical rheumatology · 2021Review
- Time of Onset of Selected Skin Lesions Associated with COVID-19: A Systematic Review.Dermatology and therapy · 2021Review
- Defining the short-term and long-term skin manifestations of COVID-19: insights after more than three years of the pandemic.Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologieReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 3 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionSince COVID-19 has become a pandemic, extensive literature has been produced. The commonest symptoms of COVID-19 disease are fever, cough, anosmia, and lymphocytopenia. However, other apparently less common clinical symptoms have been described, including skin lesions. We conducted a systematic review to evaluate skin involvement in COVID-19.
methodsThe authors performed a systematic review of literature, in accordance with the Preferred Reporting Items for Systematic and Meta-Analysis (PRISMA). The search was reiterated until May 06, 2020.
resultsOverall, 1593 patients (M/F ratio: 1 : 9) with suspect of COVID-19 were examined. The mean age was 37.8 (range 0-91) years. Among the analyzed patients, 84 (5.3%) were pediatrics (<18 years). Chilblains are very common among skin lesions and represent almost half of all skin lesions reported (46%); in 75% of patients with cutaneous manifestation, the latter presented before other typical clinical manifestation of COVID-19. Vasculitis or thrombosis was identified in almost 70% of patients who suffered from skin manifestations.
conclusionThe present study highlights the importance of skin involvement in COVID-19. Limbs should be examined to eventually foresee the onset of further typical symptoms. Chilblains can be considered typical features. Studies with higher scientific evidence are required.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.